No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Advanced Sterilization Products Receives 510(k) Clearance for ASP AEROFLEX ™ Automatic Endoscope Reprocessor

Editor: What To Know

  • To effectively disinfect a flexible endoscope, it is essential that the active ingredient in the high-level disinfectant (HLD) be at or above the level required to kill microorganisms.
  • The high-level disinfection system, which is designed to be used to clean and disinfect flexible endoscopes from a wide range of manufacturers, offers the fastest complete cycle time – just 22 minutes – of any AER currently sold in the United States.
  • Advanced Sterilization Products reports the current method requires dipping a test strip into the HLD and subjectively assessing the color change of the test strip against a visual scale.

Advanced Sterilization Products announced today they received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the ASP AEROFLEX ™ Automatic Endoscope Reprocessor (AER). The high-level disinfection system, which is designed to be used to clean and disinfect flexible endoscopes from a wide range of manufacturers, offers the fastest complete cycle time – just 22 minutes – of any AER currently sold in the United States.*

Flexible endoscopes are costly, complex and fragile instruments commonly used in minimally invasive procedures and are required to be high-level disinfected between every patient use. To effectively disinfect a flexible endoscope, it is essential that the active ingredient in the high-level disinfectant (HLD) be at or above the level required to kill microorganisms. According to professional society standards and HLD instructions for use, this critical measurement, known as the minimum recommended concentration (MRC), should be taken every time an endoscope is reprocessed.

Advanced Sterilization Products reports the current method requires dipping a test strip into the HLD and subjectively assessing the color change of the test strip against a visual scale. Given the manual nature of this process, testing may be missed or done incorrectly. AEROFLEX is the only AER with AUTOSURE™ MRC Monitor, an integrated system to automatically test HLD MRC levels every cycle, eliminating the need for manual test strips.

It is estimated that 32 million gastrointestinal (GI) endoscopy procedures using a flexible endoscope are performed each year in the United States. To keep pace with procedure demands, endoscopy managers are looking for ways to decrease the time and effort required to confidently reprocess endoscopes.

AEROFLEX with AUTOSURE is designed to ensure MRC testing compliance and increase productivity in the endoscopy suite,” said Amy Smith, Vice President of Advanced Sterilization Products. “Additionally, this is an integrated system with intuitive functionality that’s intended to be quick and easy to learn and operate. ASP remains committed to continually improving delicate instrument reprocessing with innovations that make a real difference in every day practice.”

AEROFLEX with AUTOSURE will be equipped with a touchscreen user interface and an electronic records management system designed to improve efficiency, accuracy and compliance with record keeping requirements compared to manual systems.

Note: *In countries where distributed. Includes wash, high-level disinfection, rinses, MRC testing and alcohol flush. For all qualified endoscopes except duodenoscopes which require additional time. Assuming nominal conditions for water pressure, flow rate and temperature.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy